The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer
Natalia Hermán‐Sánchez(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition)
Cited by 2
Related Papers
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma
|Cancer Gene Therapy|2024|6
The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in Pancreatic Ductal Adenocarcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0